Medicines Patent Pool: Licenses
To date, Medicines Patent Pool has signed agreements with 15 patent holders for 13 HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals, a tuberculosis treatment, two long-acting technologies, two experimental oral antiviral treatments for COVID-19 and 12 COVID-19 technologies.
June 2022
Click for full info +Medicines Patent Pool: Licenses
June 2022 |
In this Technical Brief:
Product Type(s):
- Long-Acting Therapeutics
Topic(s):
- Licenses
Region(s):
- United States, L/MICs
Full Info:
Resource Type:
Citation:
Medicines Patent Pool
Authors: Lobna Gaayeb, Long-Acting Technologies Project Manager
Health Risks(s):
- Hepatitis
- HIV
- Malaria
Product type(s):
- Injectables
- MPTs
Topic(s):
- MPTs
- Development
- Trials
Region(s)
- Global
URL of resource:
https://medicinespatentpool.org/progress-achievements/licences